palliative benefits of the multimodality approach in the re-treatment of recurrent malignant glioma: two case reports
Clicks: 280
ID: 181965
2009
Two young male patients treated seven and four years back, for malignant glioma, returned with recurrence at the same site, with a World Health Organization (WHO) Performance Score of four and two. Both underwent resurgery and received postoperative reirradiation of 5040 cGy in 28 fractions and concurrent Temozolomide 75 mg/m 2 body surface area (BSA) daily, and one patient received additional adjuvant Temozolomide 250 mg (150 mg/m 2 BSA). Both patients tolerated the treatment well with 16 and 14 months follow-up from the time of recurrence. They were symptom-free, with normal physical function and good mental state, and resumed their respective jobs.
| Reference Key |
arulponni2009indianpalliative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;T R Arulponni;M G Janaki;S Nirmala |
| Journal | Öneri |
| Year | 2009 |
| DOI | 10.4103/0973-1075.58464 |
| URL | |
| Keywords |
Cancer
Iran
Breast cancer
awareness
quality of life
hiv/aids
death
palliative care
oral cancer
prescribing practices
oncology nurses
radiation
rural areas
head and neck cancer
ptosis
radiculopathy
nurses
cancer pain
lived experience
comparative study
doctors
pregabalin
mucositis
urban areas
pain relief
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.